|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 7.070 USD | +0.28% |
|
-7.22% | -31.23% |
| Market Cap | 255M 220M 207M 188M 354M 24.19B 356M 2.45B 952M 12.31B 957M 936M 40.81B | P/E 2026 * |
-1.77x | P/E 2027 * | -1.97x |
|---|---|---|---|---|---|
| Enterprise Value | 225M 194M 182M 166M 312M 21.33B 314M 2.16B 839M 10.85B 844M 826M 35.99B | EV / Sales 2026 * |
11.8x | EV / Sales 2027 * | -1.21x |
| Free-Float |
85.77% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Entrada Therapeutics, Inc.
| 20/12/22 | Nipte winst op Wall Street | |
| 20/12/22 | Wall Street licht hoger | |
| 20/12/22 | Wall Street richting rode opening |
| 1 day | +0.28% | ||
| 1 week | -7.22% | ||
| Current month | +0.28% | ||
| 1 month | +4.12% | ||
| 3 months | +2.32% | ||
| 6 months | -40.74% | ||
| Current year | -31.23% |
| 1 week | 6.76 |  | 7.37 |
| 1 month | 6.64 | | 7.97 |
| Current year | 5.63 | | 16.45 |
| 1 year | 5.02 | | 16.45 |
| 3 years | 4.93 | | 21.79 |
| 5 years | 4.93 | | 36.85 |
| 10 years | 4.93 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 31/07/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 31/10/2020 |
Nathan Dowden
PSD | President | 56 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 31/07/2017 |
Kush Parmar
CHM | Chairman | 45 | 30/11/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 30/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | MPM BioImpact LLC
| Sell | Company | -44,259 | 0.1137% | |
| 31/08/26 | MPM BioImpact LLC
| Sell | Company | -44,259 | 0.1137% | |
| 26/08/26 | MPM BioImpact LLC
| Sell | Company | -14,569 | 0.0374% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.28% | -7.22% | +29.25% | -54.12% | 255M | |
| -0.25% | -4.10% | +38.38% | +92.61% | 68.21B | |
| +0.56% | -0.71% | +47.06% | +87.66% | 64.25B | |
| -0.25% | -1.92% | -10.72% | +436.70% | 26.54B | |
| +0.33% | -10.61% | +1.95% | -16.27% | 25.61B | |
| +1.26% | +0.97% | +31.96% | -18.14% | 19.88B | |
| -6.09% | -12.08% | +226.11% | +375.00% | 17.13B | |
| +0.65% | -5.28% | -1.12% | +534.90% | 14.93B | |
| +4.12% | +0.30% | +52.03% | +150.18% | 14.1B | |
| -0.24% | +5.18% | +23.04% | +190.97% | 12.45B | |
| Average | +0.04% | -4.25% | +43.79% | +177.95% | 26.33B | |
| Weighted average by Cap. | +0.02% | -3.23% | +41.49% | +158.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19.05M 16.43M 15.46M 14.08M 26.48M 1.81B 26.63M 183M 71.13M 920M 71.53M 69.98M 3.05B | 20M 17.25M 16.23M 14.79M 27.8M 1.9B 27.96M 192M 74.68M 966M 75.1M 73.47M 3.2B |
| Net income | -170M -147M -138M -126M -237M -16.16B -238M -1.63B -636M -8.22B -639M -625M -27.26B | -191M -165M -155M -141M -266M -18.16B -267M -1.84B -714M -9.24B -718M -703M -30.62B |
| Net Debt | -30.12M -25.98M -24.44M -22.27M -41.87M -2.86B -42.1M -289M -112M -1.45B -113M -111M -4.82B | -279M -241M -226M -206M -388M -26.49B -390M -2.68B -1.04B -13.47B -1.05B -1.03B -44.67B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$7.070 | +0.28% | 205,483 |
| 31/08/26 | US$7.050 | +0.71% | 450,412 |
| 28/08/26 | US$7.000 | -3.71% | 111,601 |
| 27/08/26 | US$7.270 | +3.86% | 248,603 |
| 26/08/26 | US$7.000 | -8.14% | 229,319 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
